# Safety Study of Once a Day ART and Opiate Substitute.

> **NCT00324688** · PHASE4 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 60 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Viread

## Key facts

- **NCT ID:** NCT00324688
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 60 (—)
- **Last updated:** 2014-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00324688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00324688, "Safety Study of Once a Day ART and Opiate Substitute.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00324688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*